The Mutation Matters: CSF Profiles of GCase , Sphingolipids, α‐Synuclein in PD GBA
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Mutation Matters:
CSF
Profiles of
GCase
, Sphingolipids, α‐Synuclein in
PD
GBA
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-02-09
DOI
10.1002/mds.28472
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- β-Glucocerebrosidase activity in GBA-linked Parkinson disease
- (2020) Young Eun Huh et al. NEUROLOGY
- Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients
- (2020) Roy N. Alcalay et al. Annals of Clinical and Translational Neurology
- Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha‐synuclein profile
- (2019) Stefanie Lerche et al. MOVEMENT DISORDERS
- Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease
- (2019) Brit Mollenhauer et al. MOVEMENT DISORDERS
- Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies
- (2019) Silvia Paciotti et al. CLINICA CHIMICA ACTA
- Parkinson's Disease: Glucocerebrosidase 1 Mutation Severity Is Associated with CSF Alpha‐Synuclein Profiles
- (2019) Stefanie Lerche et al. MOVEMENT DISORDERS
- Features ofGBA-associated Parkinson’s disease at presentation in the UKTracking Parkinson’sstudy
- (2018) Naveed Malek et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Tandem mass spectrometry assay of β-glucocerebrosidase activity in dried blood spots eliminates false positives detected in fluorescence assay
- (2018) Pavlina Wolf et al. MOLECULAR GENETICS AND METABOLISM
- Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies
- (2018) Tim E. Moors et al. MOLECULAR NEUROBIOLOGY
- Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of the mouse brain
- (2018) Penelope J. Hallett et al. NEUROBIOLOGY OF AGING
- Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels
- (2018) Anna Lisa Gündner et al. NEUROBIOLOGY OF DISEASE
- Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease
- (2017) Yumiko V. Taguchi et al. JOURNAL OF NEUROSCIENCE
- Multicenter Validation of an MMSE-MoCA Conversion Table
- (2017) David Bergeron et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid
- (2017) Mohammad Shahnawaz et al. JAMA Neurology
- Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson Disease
- (2016) Michel Boutin et al. ANALYTICAL CHEMISTRY
- Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
- (2016) Ganqiang Liu et al. ANNALS OF NEUROLOGY
- Survival and dementia inGBA-associated Parkinson's disease: The mutation matters
- (2016) Roberto Cilia et al. ANNALS OF NEUROLOGY
- Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases
- (2016) Maria J. Ferraz et al. FEBS LETTERS
- Glucocerebrosidase enzyme activity in GBA mutation Parkinson’s disease
- (2016) Roberto A. Ortega et al. JOURNAL OF CLINICAL NEUROSCIENCE
- GBA Variants Influence Motor and Non-Motor Features of Parkinson’s Disease
- (2016) Silvia Jesús et al. PLoS One
- Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies
- (2016) Graham Fairfoul et al. Annals of Clinical and Translational Neurology
- High β-glucosidase (GBA) activity not attributable to GBA1 and GBA2 in live normal and enzyme-deficient fibroblasts may emphasise the role of additional GBAs
- (2015) Klaus Harzer et al. BIOLOGICAL CHEMISTRY
- Glucocerebrosidase activity in Parkinson’s disease with and withoutGBAmutations
- (2015) Roy N. Alcalay et al. BRAIN
- Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review
- (2014) N. Malek et al. ACTA NEUROLOGICA SCANDINAVICA
- GBA-associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal study
- (2014) Kathrin Brockmann et al. MOVEMENT DISORDERS
- iPSC-derived neurons from GBA1-associated Parkinson’s disease patients show autophagic defects and impaired calcium homeostasis
- (2014) David C. Schöndorf et al. Nature Communications
- Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot Study
- (2013) Michelle M. Mielke et al. PLoS One
- Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
- (2012) Matthew E. Gegg et al. ANNALS OF NEUROLOGY
- Beta-glucosidase 1 (GBA1) is a second bile acid β-glucosidase in addition to β-glucosidase 2 (GBA2). Study in β-glucosidase deficient mice and humans
- (2012) Klaus Harzer et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A liquid chromatography/tandem mass spectrometry method for measuring the in vivo incorporation of plasma free fatty acids into intramyocellular ceramides in humans
- (2012) Agnieszka U. Blachnio-Zabielska et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
- (2011) Joseph R. Mazzulli et al. CELL
- Sphingosine-1-phosphate links glycosphingolipid metabolism to neurodegeneration via a calpain-mediated mechanism
- (2011) N Hagen et al. CELL DEATH AND DIFFERENTIATION
- GBA-associated PD presents with nonmotor characteristics
- (2011) K. Brockmann et al. NEUROLOGY
- Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
- (2009) Juliane Neumann et al. BRAIN
- Subcellular Origin of Sphingosine 1-Phosphate Is Essential for Its Toxic Effect in Lyase-deficient Neurons
- (2009) Nadine Hagen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
- (2009) S. Hoops et al. NEUROLOGY
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
- (2009) E. Sidransky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiplex Enzyme Assay Screening of Dried Blood Spots for Lysosomal Storage Disorders by Using Tandem Mass Spectrometry
- (2008) X. K. Zhang et al. CLINICAL CHEMISTRY
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started